Pipeline

Internal Oncology Programs

CD40 Agonist
APX601
TNFR2 Antagonist
APX701
SIRPα Antagonist
APX201
VISTA Antagonist

Partner Programs

Undisclosed
Ocular Disease
Undisclosed
Ocular Disease
APX003/BD0801
Oncology
APX001/SSS07
Inflammation
APX003/TK001
Ocular Disease
TRK-950
Oncology